SEC 13F Intelligence

Managers / Q1 2026

FINDELL CAPITAL MANAGEMENT LLC

CIK 0001814465 · 88 PINE STREET, SUITE 2240, NEW YORK, NY, 10005 · 646-907-5217

Reported Value
$341M
Q1 2026
Positions
18
Filings on Record
11
2019–present window
Filed
May 15, 2026
original filing

Summary

Findell Capital Management LLC reported $341M in U.S.-listed holdings across 18 positions for Q1 2026.

The portfolio is heavily concentrated: LQDA alone accounts for 38.7% of reported value.

Compared with Q4 2025, the fund opened 5 new positions and exited 3.

Portfolio Metrics

Turnover
+17.5%
vs prior filed quarter
Top-10 Concentration
+90.5%
share of reported value
Largest Position
+38.7%
Liquidia Corporation
New / Exited
5 / 3
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’23: $159MQ4 ’23Q1 ’24: $191MQ2 ’24: $207MQ2 ’24Q3 ’24: $199MQ4 ’24: $244MQ4 ’24Q1 ’25: $208MQ2 ’25: $205MQ2 ’25Q3 ’25: $253MQ4 ’25: $348MQ4 ’25Q1 ’26: $341Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 75.2%Other: 21.3%ADR: 3.4%
  • Common Stock · 75.2% · $257M
  • Other · 21.3% · $73M
  • ADR · 3.4% · $12M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
CVECENOVUS ENERGY INCNEW+375.0K375.0K+$10M$10M
ACHCACADIA HEALTHCARE COMPANY INNEW+380.0K380.0K+$9M$9M
VETVERMILION ENERGY INCNEW+370.0K370.0K+$5M$5M
APLDAPPLIED DIGITAL CORPNEW+170.0K170.0K+$4M$4M
BTUPEABODY ENGR CORPNEW+8.4K8.4K+$276,154$276,154
MLYSMINERALYS THERAPEUTICS INCADDED+152.0K202.0K+$4M$5M
DAVEDAVE INCADDED+100.0K170.0K+$14M$30M
ABVXABIVAX SAADDED+57.0K105.0K+$5M$12M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

17 positions
#IssuerClass% PortfolioValueShares
1LQDALIQUIDIA CORPORATIONhistory →COM NEW38.71%$132M3.50M
2ESTABLISHMENT LABS HLDGS INCCOM16.59%$57M997.7K
3DAVEDAVE INChistory →CLASS A COM NEW8.67%$30M170.0K
4ROOTROOT INChistory →CL A NEW4.85%$17M375.0K
5SUPER GROUP SGHC LIMITEDORD SHS4.74%$16M1.50M
6GEGGEO GROUP INChistory →COM4.31%$15M875.0K
7OPRTOPORTUN FINL CORPhistory →COM3.71%$13M2.75M
8ABVXABIVAX SAhistory →SPONSORED ADS3.42%$12M105.0K
9CVECENOVUS ENERGY INChistory →COM2.91%$10M375.0K
10ACHCACADIA HEALTHCARE COMPANY INhistory →COM2.60%$9M380.0K
11TPBTURNING PT BRANDS INChistory →COM2.41%$8M95.0K
12CELHCELSIUS HLDGS INChistory →COM NEW2.08%$7M200.0K
13MLYSMINERALYS THERAPEUTICS INChistory →COM1.60%$5M202.0K
14VETVERMILION ENERGY INChistory →COM1.49%$5M370.0K
15APLDAPPLIED DIGITAL CORPhistory →COM NEW1.18%$4M170.0K
16BTUPEABODY ENGR CORPCOM0.08%$276,1548.4K
17EHTHEHEALTH INCCOM0.07%$230,945179.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$341M18May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$348M17Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$253M15Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$205M12Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$208M13May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$244M18Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$199M21Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$207M19Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$191M18May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$159M18Feb 21, 2024RESTATEMENTchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.